Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Burrows, RF; Gan, ET; Gallus, AS; Wallace, EM; Burrows, EA
   A randomised double-blind placebo controlled trial of low molecular weightheparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study
   BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
   
   R.F. Burrows et al., "A randomised double-blind placebo controlled trial of low molecular weightheparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study", BR J OBST G, 108(8), 2001, pp. 835-839
2. Chong, BH; Gallus, AS; Cade, JF; Magnani, H; Manoharan, A; Oldmeadow, M; Arthur, C; Rickard, K; Gallo, J; Lloyd, J; Seshadri, P; Chesterman, CN
   Prospective randomised open-label comparison of danaparoid with dextran 70in the treatment of heparin-induced thrombocytopaenia with thrombosis - A clinical outcome study
   THROMBOSIS AND HAEMOSTASIS
   
   B.H. Chong et al., "Prospective randomised open-label comparison of danaparoid with dextran 70in the treatment of heparin-induced thrombocytopaenia with thrombosis - A clinical outcome study", THROMB HAEM, 86(5), 2001, pp. 1170-1175
3. Turpie, AGG; Gallus, AS; Hoek, JA
   A synthetic pentasaccharide for the prevention of deep-vein thrombosis - Reply
   NEW ENGLAND JOURNAL OF MEDICINE
   
   A.G.G. Turpie et al., "A synthetic pentasaccharide for the prevention of deep-vein thrombosis - Reply", N ENG J MED, 345(4), 2001, pp. 292-292
4. Turpie, AGG; Gallus, AS; Hoek, JA
   A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.
   NEW ENGLAND JOURNAL OF MEDICINE
   
   A.G.G. Turpie et al., "A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement.", N ENG J MED, 344(9), 2001, pp. 619-625
5. Hague, WM; North, RA; Gallus, AS; Walters, BNJ; Orlikowski, C; Burrows, RF; Cincotta, RB; Dekker, GA; Higgins, JR; Lowe, SA; Morris, JM; Peek, MJ
   Anticoagulation in pregnancy and the puerperium
   MEDICAL JOURNAL OF AUSTRALIA
   
   W.M. Hague et al., "Anticoagulation in pregnancy and the puerperium", MED J AUST, 175(5), 2001, pp. 258-263
6. Gallus, AS; Baker, RI
   Economy class syndrome - Reply
   MEDICAL JOURNAL OF AUSTRALIA
   
   A.S. Gallus e R.I. Baker, "Economy class syndrome - Reply", MED J AUST, 175(3), 2001, pp. 176-176
7. Gallus, AS; Baker, RI
   Economy class syndrome
   MEDICAL JOURNAL OF AUSTRALIA
   
   A.S. Gallus e R.I. Baker, "Economy class syndrome", MED J AUST, 174(6), 2001, pp. 264-265
8. Gallus, AS
   Chairman's comments
   HAEMOSTASIS
   
   A.S. Gallus, "Chairman's comments", HAEMOSTASIS, 30, 2000, pp. 63-63
9. Gallus, AS
   Preventing venous thromboembolism in general medical inpatients and after an ischaemic stroke
   HAEMOSTASIS
   
   A.S. Gallus, "Preventing venous thromboembolism in general medical inpatients and after an ischaemic stroke", HAEMOSTASIS, 30, 2000, pp. 64-71
10. Gallus, AS; Baker, RI; Chong, BH; Ockelford, PA; Street, AM
    Consensus guidelines for warfarin therapy - Recommendations from the Australasian Society of Thrombosis and Haemostasis
    MEDICAL JOURNAL OF AUSTRALIA
    
    A.S. Gallus et al., "Consensus guidelines for warfarin therapy - Recommendations from the Australasian Society of Thrombosis and Haemostasis", MED J AUST, 172(12), 2000, pp. 600-605
11. Buller, HR; Cariou, R; Gallus, A; Gent, M; Ginsberg, J; Prins, MH; Lensing, A; Levi, M; Nurmohammed, N; Hirsh, J; Roberts, R; ten Cate, JW; Decousus, H; Mismetti, P; Buchmuller, A; Charlet, V; Viallon, A; van der Meer, J; Meinardi, JR; Meijer, K; Piovella, F; Barone, M; Beltrametti, C; Serafini, S; Kraaijenhagen, RA; Koopman, MMW; Jagt, HHT; Muller, MBR; Kooy, MV; Nauta, S; Gallus, AS; Coghlan, D; Rich, C; Prandoni, P; Scudeller, A; Scarano, L; Girolami, A; Baker, R; Tan, E; Cooney, J; Eikelboom, J; Ninet, J; Dolmazon, C; Madoux, MHG; Coppere, B; Nenci, GG; Agnelli, G; Falcinelli, F; Morini, M; d'Angelo, A; Crippa, L; d'Angelo, SV; Chong, B; Chestreman, C; Malvin, J; Eisbacher, M; MacGillavry, MR; Brandjes, DPM; Beaumont, JFM; Olmos, RAV; Turpie, AGG; Johnson, J; Nowacki, B; Anderson, D; Pleasance, S; Mitchell, M; Ockelford, P; Bennett, A; Jones, R; Porteous, F; Weitz, J; Kearon, C; Simonneau, G; Parent, F; Douketis, J; Schnurr, T; Hainaut, P; Petit, B; Jaumotte, C; Huisman, MV; van Poelgeest, MIE; Meinders, AE; van Oostayen, JA; Beer, J; Lugli, A; Pederiva, S; Ginsberg, J; Brill-Edwards, P; Stevens, P; Bassand, JP; Seronde, MF; Kassis, J; Fortin, M; Faivre, R; Petiteau, PY; Verhaeghe, R; Wells, P; Lewandowski, B; Touchie, D; Banga, JD; Hartmann, IJC; Zeguers, VJM; Desjardins, L; Villeneuve, J; Cote, J; Bounameaux, H; Cirafici, P; Demers, C; van der Heul, C; Kruip, M
    Treatment of proximal deep vein thrombosis with a novel synthetic compound(SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation
    CIRCULATION
    
    H.R. Buller et al., "Treatment of proximal deep vein thrombosis with a novel synthetic compound(SR90107A/ORG31540) with pure anti-factor Xa activity - A phase II evaluation", CIRCULATION, 102(22), 2000, pp. 2726-2731
12. Gallus, AS
    Applying risk assessment models in orthopaedic surgery: overview of our clinical experience
    BLOOD COAGULATION & FIBRINOLYSIS
    
    A.S. Gallus, "Applying risk assessment models in orthopaedic surgery: overview of our clinical experience", BL COAG FIB, 10, 1999, pp. S53-S61
13. Cohen, AT; Gallus, AS; Haas, S; Monreal, M; Pini, M; Samama, MM
    Workshop I: The potential role of new therapies in deep vein thrombosis prophylaxis
    BLOOD COAGULATION & FIBRINOLYSIS
    
    A.T. Cohen et al., "Workshop I: The potential role of new therapies in deep vein thrombosis prophylaxis", BL COAG FIB, 10, 1999, pp. S99-S102
14. Roberts, GW; Gallus, AS; Druskeit, T; Miller, C; Jorgensen, LE; Cosh, D; Wing, LMH; Eaton, VS
    Comparison of an age adjusted warfarin loading protocol with empirical dosing and Fennerty's protocol
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE
    
    G.W. Roberts et al., "Comparison of an age adjusted warfarin loading protocol with empirical dosing and Fennerty's protocol", AUST NZ J M, 29(5), 1999, pp. 731-736
15. Gallus, AS
    Thrombolytic therapy for venous thrombosis and pulmonary embolism
    BAILLIERES CLINICAL HAEMATOLOGY
    
    A.S. Gallus, "Thrombolytic therapy for venous thrombosis and pulmonary embolism", BAIL CLIN H, 11(3), 1998, pp. 663-673
16. VANDENBELT AGM; BOSSUYT PMM; PRINS MH; GALLUS AS; BULLER HR
    REPLACING INPATIENT CARE BY OUTPATIENT CARE IN THE TREATMENT OF DEEP VENOUS THROMBOSIS - AN ECONOMIC-EVALUATION
    Thrombosis and haemostasis
    
    A.G.M. Vandenbelt et al., "REPLACING INPATIENT CARE BY OUTPATIENT CARE IN THE TREATMENT OF DEEP VENOUS THROMBOSIS - AN ECONOMIC-EVALUATION", Thrombosis and haemostasis, 79(2), 1998, pp. 259-263
17. Gallus, AS; Nurmohammed, M; Kearon, C; Prins, M
    Thromboprophylaxis in non-surgical patients: Who, when and how?
    HAEMOSTASIS
    
    A.S. Gallus et al., "Thromboprophylaxis in non-surgical patients: Who, when and how?", HAEMOSTASIS, 28, 1998, pp. 71-82
18. GALLUS AS
    PREVENTION OF POSTOPERATIVE DEEP LEG VEIN-THROMBOSIS IN PATIENTS WITHCANCER
    Thrombosis and haemostasis
    
    A.S. Gallus, "PREVENTION OF POSTOPERATIVE DEEP LEG VEIN-THROMBOSIS IN PATIENTS WITHCANCER", Thrombosis and haemostasis, 78(1), 1997, pp. 126-132
19. KUIJER PMM; GALLUS AS; CHESTERMAN CN; PRINS MH; BULLER HR
    HEMOSTATIC RISK-FACTORS AND THE RISK OF RECURRENCE IN PATIENTS WITH VENOUS THROMBOEMBOLISM
    Thrombosis and haemostasis
    
    P.M.M. Kuijer et al., "HEMOSTATIC RISK-FACTORS AND THE RISK OF RECURRENCE IN PATIENTS WITH VENOUS THROMBOEMBOLISM", Thrombosis and haemostasis, 1997, pp. 2920-2920
20. TENCATE JW; BULLER HR; GENT M; HIRSH J; PRINS MH; BAILDON R; LENSING AWA; ANDERSON DR; VANBEEK EJR; FIESINGER JN; TIJSSEN JGP; VANBARNEVELD A; EIMERS LT; GRAAFSMA YP; HETTIARACHCHI R; HUTTEN B; REDEKOP K; HALEY S; LIBERALE L; FINCH T; WHITTAKER S; WILKINSON L; PRANDONI P; VILLALTA S; GIROLAMI B; BAGATELLA P; ROSSI L; GIROLAMI A; PIOVELLA F; BARONE M; BELTRAMETTI C; SERAFINI S; SIRAGUSA S; ASCARI E; KOVACS MJ; MORROW B; KOVACS J; KUIJER PMM; KOOPMAN MMW; JAGT H; WEITZ J; KEARON C; BIAGIONI L; HAAS S; LOSSNER F; SPENGEL FA; BERGER M; DEMERS C; POULIN J; VANDERMEER J; QUE GTH; SMID WM; ROBINSON KS; BOYLE E; LECLERC JR; STJACQUES B; FINKENBINE S; GALLUS AS; COHLAN D; RICH C; BRANDJES DPM; HOEFNAGEL CA; DERIJK M; TURKSTRA F; DESJARDINS L; COTEDESJARDINS J; COUTURE L; RUEL M; VILLENUEVE J; GEERTS WH; JAY RM; CODE EKI; TURPIE AGG; JOHNSON J; NGUYEN P; CUSSON JR; ROY S; WELLS PS; BORMANIS J; GOUDIE D; CRUICKSHANK M; VONLEWINSKI M; MONREAL M; SAHUQUILLO JC; LAFOZ E; SIMONNEAU G; PARENT F; JAGOT J; DOUKETIS JD; KINNON K; GINSBERG JS; BRILLEDWARDS P; DONOVAN D; OCKELFORD PA; KASSIS J; BORNAIS S; PLANCHON B; ELKOURI D; PISTORIUS MA; ESCRIBANO M; GARRIDO G; CHESTERMAN CN; CHONG BH; PRITCHARD S; CADE JF; BYNON T; STANFORD J; BRIEN WM; PALMER B; FAIVRE R; PETITEAU B; MANUCCI PM; MOIA M; BUCCIARELLI P
    LOW-MOLECULAR-WEIGHT HEPARIN IN THE TREATMENT OF PATIENTS WITH VENOUSTHROMBOEMBOLISM
    The New England journal of medicine
    
    J.W. Tencate et al., "LOW-MOLECULAR-WEIGHT HEPARIN IN THE TREATMENT OF PATIENTS WITH VENOUSTHROMBOEMBOLISM", The New England journal of medicine, 337(10), 1997, pp. 657-662
21. KOOPMAN MMW; PRANDONI P; PIOVELLA F; OCKELFORD PA; BRANDJES DPM; VANDERMEER J; GALLUS AS; SIMONNEAU G; CHESTERMAN CH; PRINS MH; BOSSUYT PMM; DEHAES H; VANDENBELT AGM; SAGNARD L; DAZEMAR P; BULLER HR
    TREATMENT OF VENOUS THROMBOSIS WITH INTRAVENOUS UNFRACTIONATED HEPARIN ADMINISTERED IN THE HOSPITAL AS COMPARED WITH SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN ADMINISTERED AT HOME
    The New England journal of medicine
    
    M.M.W. Koopman et al., "TREATMENT OF VENOUS THROMBOSIS WITH INTRAVENOUS UNFRACTIONATED HEPARIN ADMINISTERED IN THE HOSPITAL AS COMPARED WITH SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN ADMINISTERED AT HOME", The New England journal of medicine, 334(11), 1996, pp. 682-687
22. KUIJER PMM; GALLUS AS; CADE JE; BULLER HR
    RANDOMIZED COMPARISON OF LMWH VERSUS STANDARD HEPARIN IN THE INITIAL TREATMENT OF PULMONARY-EMBOLISM
    Thrombosis and haemostasis
    
    P.M.M. Kuijer et al., "RANDOMIZED COMPARISON OF LMWH VERSUS STANDARD HEPARIN IN THE INITIAL TREATMENT OF PULMONARY-EMBOLISM", Thrombosis and haemostasis, 73(6), 1995, pp. 974-974
23. QUADROS NP; ROBERTSTHOMSON PJ; GALLUS AS
    SERA FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS DEMONSTRATE ENHANCED IGG BINDING TO ENDOTHELIAL-CELLS PRETREATED WITH TUMOR-NECROSIS-FACTOR-ALPHA
    Rheumatology international
    
    N.P. Quadros et al., "SERA FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS DEMONSTRATE ENHANCED IGG BINDING TO ENDOTHELIAL-CELLS PRETREATED WITH TUMOR-NECROSIS-FACTOR-ALPHA", Rheumatology international, 15(3), 1995, pp. 99-105
24. GALLUS AS
    ANTICOAGULANTS AND ANTIPLATELET DRUGS
    Medical journal of Australia
    
    A.S. Gallus, "ANTICOAGULANTS AND ANTIPLATELET DRUGS", Medical journal of Australia, 160(2), 1994, pp. 78-82
25. KIRKLAND MA; GALLUS AS
    CLINICAL IMPLICATIONS OF LABORATORY TESTING FOR THE THROMBOPHILIC DISORDERS
    Australian and New Zealand Journal of Medicine
    
    M.A. Kirkland e A.S. Gallus, "CLINICAL IMPLICATIONS OF LABORATORY TESTING FOR THE THROMBOPHILIC DISORDERS", Australian and New Zealand Journal of Medicine, 23(3), 1993, pp. 291-302